NCT06306443View on ClinicalTrials.gov

Buprenorphine for Individuals in Jail

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Opioid Use Disorder
Interventions
DRUG

extended-release buprenorphine (XR-B)

buprenorphine

Trial Locations (2)

21201

Friends Research Institute, Baltimore

21202

Baltimore Central Booking & Intake Center, Baltimore

Sponsors
All Listed Sponsors
lead

Friends Research Institute, Inc.

OTHER